Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma

Chinese scientists publish promising findings on clinical trials involving Avasimibe, which has shown to  inhibit tumour growth by targeting FoxM1-AKR1C1 in osteosarcoma

 

http://Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma

Cooper Rice-Brading Foundation, Research

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>